The Market Online - At The Bell

Join our daily newsletter At The Bell to receive exclusive market insights

  • VIP Gloves (VIP) shares were up over 200 per cent this morning after the company has been considered an essential service by the Malaysian Government
  • VIP Gloves says its order book is fully committed until December 2020
  • These orders represent the production of approximately 100, 40-foot shipping containers of nitrile gloves, with each container holding up to four million gloves
  • Malaysia is the world’s largest manufacturer of disposable gloves, with more than 60 per cent of global production
  • The company’s Malaysian plant is operating 24 hour days
  • VIP Gloves is currently up 123 per cent on the market today, selling shares for 7.8¢ each

VIP Gloves (VIP) shares were up over 200 per cent this morning after the company has been considered an essential service by the Malaysian Government.

Glove production is in full swing at the manufacturing plant as it is operating 24 hours a day, seven days a week.

VIP Gloves says its order book is fully committed until December 2020. These orders represent the production of approximately 100, 40-foot shipping containers of nitrile gloves, with each container holding up to four million gloves.

Malaysia is the world’s largest manufacturer of disposable gloves, with more than 60 per cent of global production.

Two new production lines

The company’s two new production lines have been affected by the supplier re-alignment and fine-tuning problems. Since both new lines are under warranty, operations can only start after the adjustments are completed.

However, the suppliers fall under the non-essential workers and VIP Gloves will have to wait until April 28, when the restrictions are over.

VIP Gloves is currently up 123 per cent on the market today, selling shares for 7.8¢ each at 2:35 pm AEST.

VIP by the numbers
More From The Market Online

PharmAust CEO’s sayanora triggers stock plunge

Clinical-stage biotechnology company, PharmAust shares plunged 24 per cent so this morning, following the resignation of…

Emyria locks in $2.3M to progress MDMA research – with Chair adding $0.3M

WA-based and ASX-listed Emyria is seeking to further research using MDMA to treat PTSD. The chair…

Genetic Signatures wins TGA greenlight for flu test device – just before winter

Genetic Signatures (ASX:GSS) shares were down -1.45% to 68cps on Monday, even as the company reported…

PYC Therapeutics takes Polycystic Kidney Disease drug to human trials

PYC Therapeutics takes its latest drug for Polycystic Kidney Disease, characterized by the formation of cysts…